Global Inactivated Influenza Virus Vaccine Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Inactivated Influenza Virus Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Inactivated Influenza Virus Vaccine players cover CSL, GSK, Sanofi Pasteur, Mylan and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Inactivated Influenza Virus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Inactivated Influenza Virus Vaccine market, with both quantitative and qualitative data, to help readers understand how the Inactivated Influenza Virus Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Inactivated Influenza Virus Vaccine market and forecasts the market size by Type (Whole Virus Vaccine and Subunit Vaccine,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Inactivated Influenza Virus Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Inactivated Influenza Virus Vaccine market size (sales and revenue) and CAGR, Inactivated Influenza Virus Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Inactivated Influenza Virus Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Inactivated Influenza Virus Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Inactivated Influenza Virus Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson, Jiangsu Jindik Biotechnology Co., Ltd and Beijing Kexing Biological Products Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion
The global market for Inactivated Influenza Virus Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Inactivated Influenza Virus Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Inactivated Influenza Virus Vaccine players cover CSL, GSK, Sanofi Pasteur, Mylan and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Inactivated Influenza Virus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Inactivated Influenza Virus Vaccine market, with both quantitative and qualitative data, to help readers understand how the Inactivated Influenza Virus Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Inactivated Influenza Virus Vaccine market and forecasts the market size by Type (Whole Virus Vaccine and Subunit Vaccine,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Whole Virus Vaccine
- Subunit Vaccine
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL
- GSK
- Sanofi Pasteur
- Mylan
- AstraZeneca
- Pfizer
- Johnson & Johnson
- Jiangsu Jindik Biotechnology Co., Ltd
- Beijing Kexing Biological Products Co., Ltd
- Jiangsu Kangrun Biotechnology Co., Ltd
- Hualan Bio Vaccines Co., Ltd
- Dalian Yalifeng Biopharmaceutical Co., Ltd
- Shanghai Institute of Biological Products Co., Ltd
- Changchun Institute of Biological Products Co., Ltd
- Lanzhou Institute of Biological Products Co., Ltd
- Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
- Emmi Chengxin Biopharmaceutical Co., Ltd
Chapter 1: Scope of Inactivated Influenza Virus Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Inactivated Influenza Virus Vaccine market size (sales and revenue) and CAGR, Inactivated Influenza Virus Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Inactivated Influenza Virus Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Inactivated Influenza Virus Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Inactivated Influenza Virus Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson, Jiangsu Jindik Biotechnology Co., Ltd and Beijing Kexing Biological Products Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Inactivated Influenza Virus Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Inactivated Influenza Virus Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Inactivated Influenza Virus Vaccine Segment by Type
2.2.1 Whole Virus Vaccine
2.2.2 Subunit Vaccine
2.3 Inactivated Influenza Virus Vaccine Sales by Type
2.3.1 Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Inactivated Influenza Virus Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Inactivated Influenza Virus Vaccine Sale Price by Type (2017-2022)
2.4 Inactivated Influenza Virus Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Inactivated Influenza Virus Vaccine Sales by Application
2.5.1 Global Inactivated Influenza Virus Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Inactivated Influenza Virus Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Inactivated Influenza Virus Vaccine Sale Price by Application (2017-2022)
3 GLOBAL INACTIVATED INFLUENZA VIRUS VACCINE BY COMPANY
3.1 Global Inactivated Influenza Virus Vaccine Breakdown Data by Company
3.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Inactivated Influenza Virus Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Inactivated Influenza Virus Vaccine Revenue by Company (2020-2022)
3.2.2 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Inactivated Influenza Virus Vaccine Sale Price by Company
3.4 Key Manufacturers Inactivated Influenza Virus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inactivated Influenza Virus Vaccine Product Location Distribution
3.4.2 Players Inactivated Influenza Virus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INACTIVATED INFLUENZA VIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Inactivated Influenza Virus Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Inactivated Influenza Virus Vaccine Annual Revenue by Geographic Region
4.2 World Historic Inactivated Influenza Virus Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Inactivated Influenza Virus Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Inactivated Influenza Virus Vaccine Annual Revenue by Country/Region
4.3 Americas Inactivated Influenza Virus Vaccine Sales Growth
4.4 APAC Inactivated Influenza Virus Vaccine Sales Growth
4.5 Europe Inactivated Influenza Virus Vaccine Sales Growth
4.6 Middle East & Africa Inactivated Influenza Virus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Inactivated Influenza Virus Vaccine Sales by Country
5.1.1 Americas Inactivated Influenza Virus Vaccine Sales by Country (2017-2022)
5.1.2 Americas Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022)
5.2 Americas Inactivated Influenza Virus Vaccine Sales by Type
5.3 Americas Inactivated Influenza Virus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inactivated Influenza Virus Vaccine Sales by Region
6.1.1 APAC Inactivated Influenza Virus Vaccine Sales by Region (2017-2022)
6.1.2 APAC Inactivated Influenza Virus Vaccine Revenue by Region (2017-2022)
6.2 APAC Inactivated Influenza Virus Vaccine Sales by Type
6.3 APAC Inactivated Influenza Virus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inactivated Influenza Virus Vaccine by Country
7.1.1 Europe Inactivated Influenza Virus Vaccine Sales by Country (2017-2022)
7.1.2 Europe Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022)
7.2 Europe Inactivated Influenza Virus Vaccine Sales by Type
7.3 Europe Inactivated Influenza Virus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inactivated Influenza Virus Vaccine by Country
8.1.1 Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Type
8.3 Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inactivated Influenza Virus Vaccine
10.3 Manufacturing Process Analysis of Inactivated Influenza Virus Vaccine
10.4 Industry Chain Structure of Inactivated Influenza Virus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inactivated Influenza Virus Vaccine Distributors
11.3 Inactivated Influenza Virus Vaccine Customer
12 WORLD FORECAST REVIEW FOR INACTIVATED INFLUENZA VIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Inactivated Influenza Virus Vaccine Market Size Forecast by Region
12.1.1 Global Inactivated Influenza Virus Vaccine Forecast by Region (2023-2028)
12.1.2 Global Inactivated Influenza Virus Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inactivated Influenza Virus Vaccine Forecast by Type
12.7 Global Inactivated Influenza Virus Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Inactivated Influenza Virus Vaccine Product Offered
13.1.3 CSL Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Inactivated Influenza Virus Vaccine Product Offered
13.2.3 GSK Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Offered
13.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Inactivated Influenza Virus Vaccine Product Offered
13.4.3 Mylan Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Inactivated Influenza Virus Vaccine Product Offered
13.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Inactivated Influenza Virus Vaccine Product Offered
13.6.3 Pfizer Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Inactivated Influenza Virus Vaccine Product Offered
13.7.3 Johnson & Johnson Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Jiangsu Jindik Biotechnology Co., Ltd
13.8.1 Jiangsu Jindik Biotechnology Co., Ltd Company Information
13.8.2 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.8.3 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Jiangsu Jindik Biotechnology Co., Ltd Main Business Overview
13.8.5 Jiangsu Jindik Biotechnology Co., Ltd Latest Developments
13.9 Beijing Kexing Biological Products Co., Ltd
13.9.1 Beijing Kexing Biological Products Co., Ltd Company Information
13.9.2 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.9.3 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Beijing Kexing Biological Products Co., Ltd Main Business Overview
13.9.5 Beijing Kexing Biological Products Co., Ltd Latest Developments
13.10 Jiangsu Kangrun Biotechnology Co., Ltd
13.10.1 Jiangsu Kangrun Biotechnology Co., Ltd Company Information
13.10.2 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.10.3 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jiangsu Kangrun Biotechnology Co., Ltd Main Business Overview
13.10.5 Jiangsu Kangrun Biotechnology Co., Ltd Latest Developments
13.11 Hualan Bio Vaccines Co., Ltd
13.11.1 Hualan Bio Vaccines Co., Ltd Company Information
13.11.2 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.11.3 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hualan Bio Vaccines Co., Ltd Main Business Overview
13.11.5 Hualan Bio Vaccines Co., Ltd Latest Developments
13.12 Dalian Yalifeng Biopharmaceutical Co., Ltd
13.12.1 Dalian Yalifeng Biopharmaceutical Co., Ltd Company Information
13.12.2 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.12.3 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dalian Yalifeng Biopharmaceutical Co., Ltd Main Business Overview
13.12.5 Dalian Yalifeng Biopharmaceutical Co., Ltd Latest Developments
13.13 Shanghai Institute of Biological Products Co., Ltd
13.13.1 Shanghai Institute of Biological Products Co., Ltd Company Information
13.13.2 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.13.3 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Institute of Biological Products Co., Ltd Main Business Overview
13.13.5 Shanghai Institute of Biological Products Co., Ltd Latest Developments
13.14 Changchun Institute of Biological Products Co., Ltd
13.14.1 Changchun Institute of Biological Products Co., Ltd Company Information
13.14.2 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.14.3 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Changchun Institute of Biological Products Co., Ltd Main Business Overview
13.14.5 Changchun Institute of Biological Products Co., Ltd Latest Developments
13.15 Lanzhou Institute of Biological Products Co., Ltd
13.15.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
13.15.2 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.15.3 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Lanzhou Institute of Biological Products Co., Ltd Main Business Overview
13.15.5 Lanzhou Institute of Biological Products Co., Ltd Latest Developments
13.16 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
13.16.1 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Company Information
13.16.2 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.16.3 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Main Business Overview
13.16.5 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Latest Developments
13.17 Emmi Chengxin Biopharmaceutical Co., Ltd
13.17.1 Emmi Chengxin Biopharmaceutical Co., Ltd Company Information
13.17.2 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.17.3 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Emmi Chengxin Biopharmaceutical Co., Ltd Main Business Overview
13.17.5 Emmi Chengxin Biopharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Inactivated Influenza Virus Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Inactivated Influenza Virus Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Inactivated Influenza Virus Vaccine Segment by Type
2.2.1 Whole Virus Vaccine
2.2.2 Subunit Vaccine
2.3 Inactivated Influenza Virus Vaccine Sales by Type
2.3.1 Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Inactivated Influenza Virus Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Inactivated Influenza Virus Vaccine Sale Price by Type (2017-2022)
2.4 Inactivated Influenza Virus Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Inactivated Influenza Virus Vaccine Sales by Application
2.5.1 Global Inactivated Influenza Virus Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Inactivated Influenza Virus Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Inactivated Influenza Virus Vaccine Sale Price by Application (2017-2022)
3 GLOBAL INACTIVATED INFLUENZA VIRUS VACCINE BY COMPANY
3.1 Global Inactivated Influenza Virus Vaccine Breakdown Data by Company
3.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Inactivated Influenza Virus Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Inactivated Influenza Virus Vaccine Revenue by Company (2020-2022)
3.2.2 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Inactivated Influenza Virus Vaccine Sale Price by Company
3.4 Key Manufacturers Inactivated Influenza Virus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inactivated Influenza Virus Vaccine Product Location Distribution
3.4.2 Players Inactivated Influenza Virus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INACTIVATED INFLUENZA VIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Inactivated Influenza Virus Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Inactivated Influenza Virus Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Inactivated Influenza Virus Vaccine Annual Revenue by Geographic Region
4.2 World Historic Inactivated Influenza Virus Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Inactivated Influenza Virus Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Inactivated Influenza Virus Vaccine Annual Revenue by Country/Region
4.3 Americas Inactivated Influenza Virus Vaccine Sales Growth
4.4 APAC Inactivated Influenza Virus Vaccine Sales Growth
4.5 Europe Inactivated Influenza Virus Vaccine Sales Growth
4.6 Middle East & Africa Inactivated Influenza Virus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Inactivated Influenza Virus Vaccine Sales by Country
5.1.1 Americas Inactivated Influenza Virus Vaccine Sales by Country (2017-2022)
5.1.2 Americas Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022)
5.2 Americas Inactivated Influenza Virus Vaccine Sales by Type
5.3 Americas Inactivated Influenza Virus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inactivated Influenza Virus Vaccine Sales by Region
6.1.1 APAC Inactivated Influenza Virus Vaccine Sales by Region (2017-2022)
6.1.2 APAC Inactivated Influenza Virus Vaccine Revenue by Region (2017-2022)
6.2 APAC Inactivated Influenza Virus Vaccine Sales by Type
6.3 APAC Inactivated Influenza Virus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inactivated Influenza Virus Vaccine by Country
7.1.1 Europe Inactivated Influenza Virus Vaccine Sales by Country (2017-2022)
7.1.2 Europe Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022)
7.2 Europe Inactivated Influenza Virus Vaccine Sales by Type
7.3 Europe Inactivated Influenza Virus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inactivated Influenza Virus Vaccine by Country
8.1.1 Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Type
8.3 Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inactivated Influenza Virus Vaccine
10.3 Manufacturing Process Analysis of Inactivated Influenza Virus Vaccine
10.4 Industry Chain Structure of Inactivated Influenza Virus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inactivated Influenza Virus Vaccine Distributors
11.3 Inactivated Influenza Virus Vaccine Customer
12 WORLD FORECAST REVIEW FOR INACTIVATED INFLUENZA VIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Inactivated Influenza Virus Vaccine Market Size Forecast by Region
12.1.1 Global Inactivated Influenza Virus Vaccine Forecast by Region (2023-2028)
12.1.2 Global Inactivated Influenza Virus Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inactivated Influenza Virus Vaccine Forecast by Type
12.7 Global Inactivated Influenza Virus Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Inactivated Influenza Virus Vaccine Product Offered
13.1.3 CSL Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Inactivated Influenza Virus Vaccine Product Offered
13.2.3 GSK Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Offered
13.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Inactivated Influenza Virus Vaccine Product Offered
13.4.3 Mylan Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Inactivated Influenza Virus Vaccine Product Offered
13.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Inactivated Influenza Virus Vaccine Product Offered
13.6.3 Pfizer Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Inactivated Influenza Virus Vaccine Product Offered
13.7.3 Johnson & Johnson Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Jiangsu Jindik Biotechnology Co., Ltd
13.8.1 Jiangsu Jindik Biotechnology Co., Ltd Company Information
13.8.2 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.8.3 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Jiangsu Jindik Biotechnology Co., Ltd Main Business Overview
13.8.5 Jiangsu Jindik Biotechnology Co., Ltd Latest Developments
13.9 Beijing Kexing Biological Products Co., Ltd
13.9.1 Beijing Kexing Biological Products Co., Ltd Company Information
13.9.2 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.9.3 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Beijing Kexing Biological Products Co., Ltd Main Business Overview
13.9.5 Beijing Kexing Biological Products Co., Ltd Latest Developments
13.10 Jiangsu Kangrun Biotechnology Co., Ltd
13.10.1 Jiangsu Kangrun Biotechnology Co., Ltd Company Information
13.10.2 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.10.3 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jiangsu Kangrun Biotechnology Co., Ltd Main Business Overview
13.10.5 Jiangsu Kangrun Biotechnology Co., Ltd Latest Developments
13.11 Hualan Bio Vaccines Co., Ltd
13.11.1 Hualan Bio Vaccines Co., Ltd Company Information
13.11.2 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.11.3 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hualan Bio Vaccines Co., Ltd Main Business Overview
13.11.5 Hualan Bio Vaccines Co., Ltd Latest Developments
13.12 Dalian Yalifeng Biopharmaceutical Co., Ltd
13.12.1 Dalian Yalifeng Biopharmaceutical Co., Ltd Company Information
13.12.2 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.12.3 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dalian Yalifeng Biopharmaceutical Co., Ltd Main Business Overview
13.12.5 Dalian Yalifeng Biopharmaceutical Co., Ltd Latest Developments
13.13 Shanghai Institute of Biological Products Co., Ltd
13.13.1 Shanghai Institute of Biological Products Co., Ltd Company Information
13.13.2 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.13.3 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Institute of Biological Products Co., Ltd Main Business Overview
13.13.5 Shanghai Institute of Biological Products Co., Ltd Latest Developments
13.14 Changchun Institute of Biological Products Co., Ltd
13.14.1 Changchun Institute of Biological Products Co., Ltd Company Information
13.14.2 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.14.3 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Changchun Institute of Biological Products Co., Ltd Main Business Overview
13.14.5 Changchun Institute of Biological Products Co., Ltd Latest Developments
13.15 Lanzhou Institute of Biological Products Co., Ltd
13.15.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
13.15.2 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.15.3 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Lanzhou Institute of Biological Products Co., Ltd Main Business Overview
13.15.5 Lanzhou Institute of Biological Products Co., Ltd Latest Developments
13.16 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
13.16.1 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Company Information
13.16.2 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.16.3 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Main Business Overview
13.16.5 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Latest Developments
13.17 Emmi Chengxin Biopharmaceutical Co., Ltd
13.17.1 Emmi Chengxin Biopharmaceutical Co., Ltd Company Information
13.17.2 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
13.17.3 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Emmi Chengxin Biopharmaceutical Co., Ltd Main Business Overview
13.17.5 Emmi Chengxin Biopharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Inactivated Influenza Virus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Inactivated Influenza Virus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Whole Virus Vaccine
Table 4. Major Players of Subunit Vaccine
Table 5. Global Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Inactivated Influenza Virus Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Inactivated Influenza Virus Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Inactivated Influenza Virus Vaccine Revenue by Application (2017-2022)
Table 13. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Inactivated Influenza Virus Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Inactivated Influenza Virus Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Inactivated Influenza Virus Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Inactivated Influenza Virus Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Inactivated Influenza Virus Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Inactivated Influenza Virus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Inactivated Influenza Virus Vaccine Products Offered
Table 22. Inactivated Influenza Virus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Inactivated Influenza Virus Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Inactivated Influenza Virus Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Inactivated Influenza Virus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Inactivated Influenza Virus Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Inactivated Influenza Virus Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Inactivated Influenza Virus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Inactivated Influenza Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Inactivated Influenza Virus Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Inactivated Influenza Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Inactivated Influenza Virus Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Inactivated Influenza Virus Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Inactivated Influenza Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Inactivated Influenza Virus Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Inactivated Influenza Virus Vaccine
Table 66. Key Market Challenges & Risks of Inactivated Influenza Virus Vaccine
Table 67. Key Industry Trends of Inactivated Influenza Virus Vaccine
Table 68. Inactivated Influenza Virus Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Inactivated Influenza Virus Vaccine Distributors List
Table 71. Inactivated Influenza Virus Vaccine Customer List
Table 72. Global Inactivated Influenza Virus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Inactivated Influenza Virus Vaccine Sales Market Forecast by Region
Table 74. Global Inactivated Influenza Virus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Inactivated Influenza Virus Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Inactivated Influenza Virus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Inactivated Influenza Virus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Inactivated Influenza Virus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Inactivated Influenza Virus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Inactivated Influenza Virus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Inactivated Influenza Virus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Inactivated Influenza Virus Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Inactivated Influenza Virus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Inactivated Influenza Virus Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Inactivated Influenza Virus Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Inactivated Influenza Virus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Inactivated Influenza Virus Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Inactivated Influenza Virus Vaccine Product Offered
Table 94. CSL Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. CSL Main Business
Table 96. CSL Latest Developments
Table 97. GSK Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Inactivated Influenza Virus Vaccine Product Offered
Table 99. GSK Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Sanofi Pasteur Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Offered
Table 104. Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Pasteur Main Business
Table 106. Sanofi Pasteur Latest Developments
Table 107. Mylan Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Inactivated Influenza Virus Vaccine Product Offered
Table 109. Mylan Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Mylan Main Business
Table 111. Mylan Latest Developments
Table 112. AstraZeneca Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca Inactivated Influenza Virus Vaccine Product Offered
Table 114. AstraZeneca Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. AstraZeneca Main Business
Table 116. AstraZeneca Latest Developments
Table 117. Pfizer Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer Inactivated Influenza Virus Vaccine Product Offered
Table 119. Pfizer Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. Johnson & Johnson Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson & Johnson Inactivated Influenza Virus Vaccine Product Offered
Table 124. Johnson & Johnson Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments
Table 127. Jiangsu Jindik Biotechnology Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 129. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Jiangsu Jindik Biotechnology Co., Ltd Main Business
Table 131. Jiangsu Jindik Biotechnology Co., Ltd Latest Developments
Table 132. Beijing Kexing Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 134. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Beijing Kexing Biological Products Co., Ltd Main Business
Table 136. Beijing Kexing Biological Products Co., Ltd Latest Developments
Table 137. Jiangsu Kangrun Biotechnology Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 139. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Jiangsu Kangrun Biotechnology Co., Ltd Main Business
Table 141. Jiangsu Kangrun Biotechnology Co., Ltd Latest Developments
Table 142. Hualan Bio Vaccines Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 144. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Hualan Bio Vaccines Co., Ltd Main Business
Table 146. Hualan Bio Vaccines Co., Ltd Latest Developments
Table 147. Dalian Yalifeng Biopharmaceutical Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 149. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dalian Yalifeng Biopharmaceutical Co., Ltd Main Business
Table 151. Dalian Yalifeng Biopharmaceutical Co., Ltd Latest Developments
Table 152. Shanghai Institute of Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 154. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Shanghai Institute of Biological Products Co., Ltd Main Business
Table 156. Shanghai Institute of Biological Products Co., Ltd Latest Developments
Table 157. Changchun Institute of Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 159. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Changchun Institute of Biological Products Co., Ltd Main Business
Table 161. Changchun Institute of Biological Products Co., Ltd Latest Developments
Table 162. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 164. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Lanzhou Institute of Biological Products Co., Ltd Main Business
Table 166. Lanzhou Institute of Biological Products Co., Ltd Latest Developments
Table 167. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 169. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Main Business
Table 171. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Latest Developments
Table 172. Emmi Chengxin Biopharmaceutical Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 174. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Emmi Chengxin Biopharmaceutical Co., Ltd Main Business
Table 176. Emmi Chengxin Biopharmaceutical Co., Ltd Latest Developments
Table 1. Inactivated Influenza Virus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Inactivated Influenza Virus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Whole Virus Vaccine
Table 4. Major Players of Subunit Vaccine
Table 5. Global Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Inactivated Influenza Virus Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Inactivated Influenza Virus Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Inactivated Influenza Virus Vaccine Revenue by Application (2017-2022)
Table 13. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Inactivated Influenza Virus Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Inactivated Influenza Virus Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Inactivated Influenza Virus Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Inactivated Influenza Virus Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Inactivated Influenza Virus Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Inactivated Influenza Virus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Inactivated Influenza Virus Vaccine Products Offered
Table 22. Inactivated Influenza Virus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Inactivated Influenza Virus Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Inactivated Influenza Virus Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Inactivated Influenza Virus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Inactivated Influenza Virus Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Inactivated Influenza Virus Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Inactivated Influenza Virus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Inactivated Influenza Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Inactivated Influenza Virus Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Inactivated Influenza Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Inactivated Influenza Virus Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Inactivated Influenza Virus Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Inactivated Influenza Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Inactivated Influenza Virus Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Inactivated Influenza Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Inactivated Influenza Virus Vaccine
Table 66. Key Market Challenges & Risks of Inactivated Influenza Virus Vaccine
Table 67. Key Industry Trends of Inactivated Influenza Virus Vaccine
Table 68. Inactivated Influenza Virus Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Inactivated Influenza Virus Vaccine Distributors List
Table 71. Inactivated Influenza Virus Vaccine Customer List
Table 72. Global Inactivated Influenza Virus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Inactivated Influenza Virus Vaccine Sales Market Forecast by Region
Table 74. Global Inactivated Influenza Virus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Inactivated Influenza Virus Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Inactivated Influenza Virus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Inactivated Influenza Virus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Inactivated Influenza Virus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Inactivated Influenza Virus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Inactivated Influenza Virus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Inactivated Influenza Virus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Inactivated Influenza Virus Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Inactivated Influenza Virus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Inactivated Influenza Virus Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Inactivated Influenza Virus Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Inactivated Influenza Virus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Inactivated Influenza Virus Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Inactivated Influenza Virus Vaccine Product Offered
Table 94. CSL Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. CSL Main Business
Table 96. CSL Latest Developments
Table 97. GSK Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Inactivated Influenza Virus Vaccine Product Offered
Table 99. GSK Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Sanofi Pasteur Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Offered
Table 104. Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Pasteur Main Business
Table 106. Sanofi Pasteur Latest Developments
Table 107. Mylan Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Inactivated Influenza Virus Vaccine Product Offered
Table 109. Mylan Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Mylan Main Business
Table 111. Mylan Latest Developments
Table 112. AstraZeneca Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca Inactivated Influenza Virus Vaccine Product Offered
Table 114. AstraZeneca Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. AstraZeneca Main Business
Table 116. AstraZeneca Latest Developments
Table 117. Pfizer Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer Inactivated Influenza Virus Vaccine Product Offered
Table 119. Pfizer Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. Johnson & Johnson Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson & Johnson Inactivated Influenza Virus Vaccine Product Offered
Table 124. Johnson & Johnson Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments
Table 127. Jiangsu Jindik Biotechnology Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 129. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Jiangsu Jindik Biotechnology Co., Ltd Main Business
Table 131. Jiangsu Jindik Biotechnology Co., Ltd Latest Developments
Table 132. Beijing Kexing Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 134. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Beijing Kexing Biological Products Co., Ltd Main Business
Table 136. Beijing Kexing Biological Products Co., Ltd Latest Developments
Table 137. Jiangsu Kangrun Biotechnology Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 139. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Jiangsu Kangrun Biotechnology Co., Ltd Main Business
Table 141. Jiangsu Kangrun Biotechnology Co., Ltd Latest Developments
Table 142. Hualan Bio Vaccines Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 144. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Hualan Bio Vaccines Co., Ltd Main Business
Table 146. Hualan Bio Vaccines Co., Ltd Latest Developments
Table 147. Dalian Yalifeng Biopharmaceutical Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 149. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dalian Yalifeng Biopharmaceutical Co., Ltd Main Business
Table 151. Dalian Yalifeng Biopharmaceutical Co., Ltd Latest Developments
Table 152. Shanghai Institute of Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 154. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Shanghai Institute of Biological Products Co., Ltd Main Business
Table 156. Shanghai Institute of Biological Products Co., Ltd Latest Developments
Table 157. Changchun Institute of Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 159. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Changchun Institute of Biological Products Co., Ltd Main Business
Table 161. Changchun Institute of Biological Products Co., Ltd Latest Developments
Table 162. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 164. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Lanzhou Institute of Biological Products Co., Ltd Main Business
Table 166. Lanzhou Institute of Biological Products Co., Ltd Latest Developments
Table 167. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 169. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Main Business
Table 171. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Latest Developments
Table 172. Emmi Chengxin Biopharmaceutical Co., Ltd Basic Information, Inactivated Influenza Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Offered
Table 174. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Emmi Chengxin Biopharmaceutical Co., Ltd Main Business
Table 176. Emmi Chengxin Biopharmaceutical Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Inactivated Influenza Virus Vaccine
Figure 2. Inactivated Influenza Virus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inactivated Influenza Virus Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Inactivated Influenza Virus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Inactivated Influenza Virus Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Whole Virus Vaccine
Figure 10. Product Picture of Subunit Vaccine
Figure 11. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type in 2021
Figure 12. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Inactivated Influenza Virus Vaccine Consumed in Hospital
Figure 14. Global Inactivated Influenza Virus Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Inactivated Influenza Virus Vaccine Consumed in Clinic
Figure 16. Global Inactivated Influenza Virus Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Application in 2021
Figure 19. Inactivated Influenza Virus Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Inactivated Influenza Virus Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Inactivated Influenza Virus Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Inactivated Influenza Virus Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Inactivated Influenza Virus Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Inactivated Influenza Virus Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Inactivated Influenza Virus Vaccine
Figure 63. Industry Chain Structure of Inactivated Influenza Virus Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 1. Picture of Inactivated Influenza Virus Vaccine
Figure 2. Inactivated Influenza Virus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inactivated Influenza Virus Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Inactivated Influenza Virus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Inactivated Influenza Virus Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Whole Virus Vaccine
Figure 10. Product Picture of Subunit Vaccine
Figure 11. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type in 2021
Figure 12. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Inactivated Influenza Virus Vaccine Consumed in Hospital
Figure 14. Global Inactivated Influenza Virus Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Inactivated Influenza Virus Vaccine Consumed in Clinic
Figure 16. Global Inactivated Influenza Virus Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Application in 2021
Figure 19. Inactivated Influenza Virus Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Inactivated Influenza Virus Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Inactivated Influenza Virus Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Inactivated Influenza Virus Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Inactivated Influenza Virus Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Inactivated Influenza Virus Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Inactivated Influenza Virus Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Inactivated Influenza Virus Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Inactivated Influenza Virus Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Inactivated Influenza Virus Vaccine
Figure 63. Industry Chain Structure of Inactivated Influenza Virus Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
